Chatham Lodging Trust reported strong Q2 2026 results with AFFO per diluted share up 22% to $0.48 and RevPAR for July soaring 10% to an all-time high of $169. Revenue per available room increased over 3% driven by strong performance in Silicon Valley and a recently acquired hotel portfolio. The company expanded hotel margins and raised its full-year guidance, reflecting confidence in continued growth. Share repurchases and new hotel construction plans further support its positive outlook.
The ProShares S&P 500 Ex-Technology ETF (SPXT) aims to reduce the heavy concentration of IT stocks in the S&P 500 but struggles to outperform the broader market. SPXT cannot completely avoid tech-like exposures, and excluding IT sector stocks limits ...
As of August 11, 2026, Tron (TRX) trades around $0.3347, positioned in the middle of its 12-month range between a low of $0.2692 and a high of $0.3753. The price shows little momentum and moves sideways near its 50- and 200-day moving averages, indic...
Analyst Barrington raised ICF International's price target to $110, suggesting a 24.45% upside from $88.39. The company expects 3% revenue growth and 5% non-GAAP EPS growth in 2026, fueled by energy, AI, and federal modernization efforts. Q2 2026 ear...
HSBC has upgraded YPF's rating to Buy following strong Q2 2026 results, including a 41.7% revenue increase to $6.57 billion and earnings per share of $3.07, surpassing estimates. YPF raised its 2026 adjusted EBITDA guidance to $8 billion and aims for...
Vivos Therapeutics reported Q2 2026 earnings per share of -$0.31, beating analyst expectations of -$0.42, but its revenue of $5.15 million fell short of the $5.63 million estimate. The company, focused on sleep apnea treatments, sees growing patient ...
